Search Results - "Huggins, John P"
-
1
Pregabalin Rectifies Aberrant Brain Chemistry, Connectivity, and Functional Response in Chronic Pain Patients
Published in Anesthesiology (Philadelphia) (01-12-2013)“…Chronic pain remains a significant challenge for modern health care as its pathologic mechanisms are largely unknown and preclinical animal models suffer from…”
Get full text
Journal Article -
2
Assessment of the pharmacology and tolerability of PF‐04457845, an irreversible inhibitor of fatty acid amide hydrolase‐1, in healthy subjects
Published in British journal of clinical pharmacology (01-05-2012)“…WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT • Inhibition of fatty acid amide hydrolase‐1 (FAAH1) and the subsequent elevation of fatty acid amides has been…”
Get full text
Journal Article -
3
Alterations in resting-state regional cerebral blood flow demonstrate ongoing pain in osteoarthritis: An arterial spin-labeled magnetic resonance imaging study
Published in Arthritis & rheumatology (Hoboken, N.J.) (01-12-2012)“…Objective Increasing evidence suggests a central nervous system (CNS) component underpinning persistent pain disease states. This study was undertaken to…”
Get full text
Journal Article -
4
Beyond patient reported pain: perfusion magnetic resonance imaging demonstrates reproducible cerebral representation of ongoing post-surgical pain
Published in PloS one (23-02-2011)“…Development of treatments for acute and chronic pain conditions remains a challenge, with an unmet need for improved sensitivity and reproducibility in…”
Get full text
Journal Article -
5
An efficient randomised, placebo-controlled clinical trial with the irreversible fatty acid amide hydrolase-1 inhibitor PF-04457845, which modulates endocannabinoids but fails to induce effective analgesia in patients with pain due to osteoarthritis of the knee
Published in Pain (Amsterdam) (01-09-2012)“…A randomised, placebo-controlled clinical trial with PF-04457845, a novel irreversible fatty acid amide hydrolase-1 inhibitor, increases endocannabinoids, but…”
Get full text
Journal Article -
6
Cognitive testing in early-phase clinical trials: Development of a rapid computerized test battery and application in a simulated Phase I study
Published in Contemporary clinical trials (01-07-2007)“…Abstract Background Inclusion of cognitive assessment in Phase I trials of novel pharmaceutical agents may help identify subtle yet meaningful CNS effects…”
Get full text
Journal Article -
7
A Potent, Selective Inhibitor of Matrix Metalloproteinase-3 for the Topical Treatment of Chronic Dermal Ulcers
Published in Journal of medicinal chemistry (31-07-2003)“…The pathology of chronic dermal ulcers is characterized by excessive proteolytic activity which degrades extracellular matrix (required for cell migration) and…”
Get full text
Journal Article -
8
Safety and tolerability of LBR-101, a humanized monoclonal antibody that blocks the binding of CGRP to its receptor: Results of the Phase 1 program
Published in Cephalalgia (01-06-2014)“…LBR-101 is a fully humanized monoclonal antibody that binds to calcitonin gene-related peptide. The objective of this article is to characterize the safety and…”
Get more information
Journal Article -
9
Pharmacologic Modulation of Hand Pain in Osteoarthritis: A Double‐Blind Placebo‐Controlled Functional Magnetic Resonance Imaging Study Using Naproxen
Published in Arthritis & rheumatology (Hoboken, N.J.) (01-03-2015)“…Objective In an attempt to shed light on management of chronic pain conditions, there has long been a desire to complement behavioral measures of pain…”
Get full text
Journal Article -
10
Multivariate decoding of cerebral blood flow measures in a clinical model of on-going postsurgical pain
Published in Human brain mapping (01-02-2015)“…Recent reports of multivariate machine learning (ML) techniques have highlighted their potential use to detect prognostic and diagnostic markers of pain…”
Get full text
Journal Article -
11
Selective Urokinase-Type Plasminogen Activator Inhibitors. 4. 1-(7-Sulfonamidoisoquinolinyl)guanidines
Published in Journal of medicinal chemistry (17-05-2007)“…1-Isoquinolinylguanidines were previously disclosed as potent and selective inhibitors of urokinase-type plasminogen activator (uPA). Further investigation of…”
Get full text
Journal Article -
12
Quantifying the test-retest reliability of cerebral blood flow measurements in a clinical model of on-going post-surgical pain: A study using pseudo-continuous arterial spin labelling
Published in NeuroImage clinical (01-01-2013)“…Arterial spin labelling (ASL) is increasingly being applied to study the cerebral response to pain in both experimental human models and patients with…”
Get full text
Journal Article -
13
An academia–industry partnership in health care
Published in The Lancet (British edition) (02-05-2009)“…[...] they can more fully appreciate the benefits and limitations of the drugs they will one day prescribe.2 The programme ranges from insight into innovative…”
Get full text
Journal Article -
14
Effects of Gabapentin on Experimental Somatic Pain and Temporal Summation
Published in Regional anesthesia and pain medicine (01-09-2007)“…Gabapentin is used for treatment of neuropathic pain, but its effect on different somatic pain modalities and integrative mechanisms are not completely…”
Get full text
Journal Article -
15
An academia–industry partnership
Published in The Lancet (British edition) (12-09-2009)“…[...] it illustrates the lack of understanding of the fundamentals of the drug development process, the very issue our partnership with BSMS attempts to…”
Get full text
Journal Article -
16
Cognitive testing in early phase clinical trials: outcome according to adverse event profile in a Phase I study
Published in Human psychopharmacology (01-10-2006)“…Background It has been proposed that objective cognitive testing provides additional information to that collected via adverse event (AE) recordings. However,…”
Get full text
Journal Article -
17
A scientist reads Job 42.3
Published in Theology (Norwich) (01-07-2018)“…As a scientist, I read Job 42.3 by noting that both science and theology are limited in their capacity to understand our world and the divine nature. However,…”
Get full text
Journal Article -
18
Effects of cyclic GMP on the secondary structure of cyclic GMP dependent protein kinase and an analysis of the enzymes and amino-terminal domain by far-ultraviolet circular dichroism
Published in Biochemistry (Easton) (01-10-1990)“…Far-UV circular dichroism spectra of bovine lung cyclic GMP dependent protein kinase (G-kinase) show that the enzyme contains alpha-helical and beta-pleated…”
Get full text
Journal Article -
19
Proton NMR and circular dichroism studies of the N-terminal domain of cyclic GMP dependent protein kinase: a leucine/isoleucine zipper
Published in Biochemistry (Easton) (01-10-1991)Get full text
Journal Article -
20
Evidence for a phosphorylation-induced conformational change in phospholamban from the effects of three proteases
Published in FEBS letters (08-06-1987)“…The effect of the proteases trypsin, thermolysin and papain on the cardiac membrane protein phospholamban was examined before or after phosphorylating the…”
Get full text
Journal Article